domingo, 22 de abril de 2018

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology | Oncology | JAMA Oncology | JAMA Network

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology | Oncology | JAMA Oncology | JAMA Network

Original Investigation
April 17, 2018

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology

JAMA Oncol. Published online April 17, 2018. doi:10.1001/jamaoncol.2018.1660

No hay comentarios:

Publicar un comentario